- Investing Ideas
- Danish Pharmaceuticals & Biotech Potentially Undervalued Companies
Danish Pharmaceuticals & Biotech Potentially Undervalued Companies
Results
5
Companies with a Value score of at least 3, ordered by Value score
5 companies
Bavarian Nordic
Market Cap: DKK 16.1b
Develops, manufactures, and supplies life-saving vaccines.
BAVA
DKK 218.00
7D
15.3%
1Y
-8.8%
H. Lundbeck
Market Cap: DKK 41.1b
Engages in the research, development, manufacturing, and commercializing pharmaceuticals for the treatment of psychiatric and neurological disorders in Europe, United States, and internationally.
HLUN B
DKK 42.80
7D
-2.5%
1Y
9.5%
Novo Nordisk
Market Cap: DKK 1.3t
Engages in the research and development, manufacture, and distribution of pharmaceutical products.
NOVO B
DKK 307.80
7D
3.9%
1Y
-12.3%
H. Lundbeck
Market Cap: DKK 41.1b
Engages in the research, development, manufacturing, and commercializing pharmaceuticals for the treatment of psychiatric and neurological disorders in Europe, United States, and internationally.
HLUN A
DKK 42.50
7D
15.3%
1Y
31.2%
Strategic Partners
Market Cap: DKK 29.2m
Does not have significant operations.
STRAP
DKK 740.00
7D
6.5%
1Y
-28.8%